NM_152726.3:c.1200+188G>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_152726.3(MICU2):c.1200+188G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.95 in 152,276 control chromosomes in the GnomAD database, including 68,860 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.95 ( 68860 hom., cov: 32)
Consequence
MICU2
NM_152726.3 intron
NM_152726.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.122
Publications
0 publications found
Genes affected
MICU2 (HGNC:31830): (mitochondrial calcium uptake 2) Enables protein heterodimerization activity. Involved in calcium import into the mitochondrion and negative regulation of mitochondrial calcium ion concentration. Located in mitochondrial inner membrane and mitochondrial intermembrane space. Part of uniplex complex. [provided by Alliance of Genome Resources, Apr 2022]
MICU2 Gene-Disease associations (from GenCC):
- mitochondrial diseaseInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.977 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MICU2 | NM_152726.3 | c.1200+188G>C | intron_variant | Intron 11 of 11 | ENST00000382374.9 | NP_689939.1 | ||
| MICU2 | XM_047430142.1 | c.930+188G>C | intron_variant | Intron 12 of 12 | XP_047286098.1 | |||
| MICU2 | XM_017020433.2 | c.654+188G>C | intron_variant | Intron 10 of 10 | XP_016875922.1 | |||
| MICU2 | XM_047430143.1 | c.*325G>C | downstream_gene_variant | XP_047286099.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.950 AC: 144577AN: 152158Hom.: 68821 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
144577
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.950 AC: 144673AN: 152276Hom.: 68860 Cov.: 32 AF XY: 0.951 AC XY: 70842AN XY: 74460 show subpopulations
GnomAD4 genome
AF:
AC:
144673
AN:
152276
Hom.:
Cov.:
32
AF XY:
AC XY:
70842
AN XY:
74460
show subpopulations
African (AFR)
AF:
AC:
36735
AN:
41542
American (AMR)
AF:
AC:
14950
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
3405
AN:
3470
East Asian (EAS)
AF:
AC:
5184
AN:
5184
South Asian (SAS)
AF:
AC:
4795
AN:
4828
European-Finnish (FIN)
AF:
AC:
10104
AN:
10598
Middle Eastern (MID)
AF:
AC:
290
AN:
294
European-Non Finnish (NFE)
AF:
AC:
66289
AN:
68040
Other (OTH)
AF:
AC:
2024
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
346
693
1039
1386
1732
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
910
1820
2730
3640
4550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3438
AN:
3472
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.